
Build-A-Bear Workshop (BBW) and Abbott Laboratories (ABT) are highlighted as attractive dividend stocks trading near their lows with yields around 3%. BBW benefits from a debt-free balance sheet, aggressive share buybacks, and international expansion, targeting a 9.3% earnings growth rate and over 70% upside to its $62 price target. ABT is undervalued with a forward P/E of 15.31, strong liquidity, ongoing buybacks, and insider buying despite some segment weakness and lowered guidance. Both companies are expected to deliver significant upside over the next 6 to 12 months, supported by strong fundamentals and resilient dividends amid market volatility.